These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28178721)

  • 41. Hyperthermic isolated hepatic perfusion using melphalan for patients with ocular melanoma metastatic to liver.
    Alexander HR; Libutti SK; Pingpank JF; Steinberg SM; Bartlett DL; Helsabeck C; Beresneva T
    Clin Cancer Res; 2003 Dec; 9(17):6343-9. PubMed ID: 14695133
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Repeated percutaneous hepatic perfusion with melphalan can maintain long-term response in patients with liver cancers.
    Veelken R; Maiwald B; Strocka S; Petersen TO; Moche M; Ebel S; Denecke T; Rehak M; Struck MF; Forstmeyer D; Rademacher S; Seehofer D; Berg T; van Bömmel F
    Cardiovasc Intervent Radiol; 2022 Feb; 45(2):218-222. PubMed ID: 34716470
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outcome analysis of a decade-long experience of isolated hepatic perfusion for unresectable liver metastases at a single institution.
    Magge D; Choudry HA; Zeh HJ; Cunningham DE; Steel J; Holtzman MP; Jones HL; Pingpank JF; Bartlett DL; Zureikat AH
    Ann Surg; 2014 May; 259(5):953-9. PubMed ID: 24169176
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatic Perfusion Therapy.
    Rajeev R; Gamblin TC; Turaga KK
    Surg Clin North Am; 2016 Apr; 96(2):357-68. PubMed ID: 27017869
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of melphalan, oxaliplatin, and paclitaxel in colon, liver, and gastric cancer cell lines in a short-term exposure model of chemosaturation therapy by percutaneous hepatic perfusion.
    Uzgare RP; Sheets TP; Johnston DS
    Anticancer Res; 2013 May; 33(5):1989-2000. PubMed ID: 23645748
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-Term Follow-Up Evaluation of 68 Patients with Uveal Melanoma Liver Metastases Treated with Isolated Hepatic Perfusion.
    Ben-Shabat I; Belgrano V; Ny L; Nilsson J; Lindnér P; Olofsson Bagge R
    Ann Surg Oncol; 2016 Apr; 23(4):1327-34. PubMed ID: 26628434
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Liver transplantation in a patient with unresectable colorectal liver metastases -- a case report.
    Hrehoreţ D; Alexandrescu S; Braşoveanu V; Grigorie R; Zielinski C; Popescu I
    Chirurgia (Bucur); 2013; 108(5):719-24. PubMed ID: 24157119
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Isolated hepatic perfusion with extracorporeal oxygenation using hyperthermia, tumour necrosis factor alpha and melphalan.
    Lindnér P; Fjälling M; Hafström L; Kierulff-Nielsen H; Mattsson J; Scherstén T; Rizell M; Naredi P
    Eur J Surg Oncol; 1999 Apr; 25(2):179-85. PubMed ID: 10218462
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictive Parameters in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan for Unresectable Liver Metastases from Uveal Melanoma: A Retrospective Pooled Analysis.
    Tong TML; Samim M; Kapiteijn E; Meijer TS; Speetjens FM; Brüning R; Schroeder TH; El-Sanosy S; Maschke H; Wacker FK; Vogel A; Dewald CLA; Goeman JJ; Burgmans MC
    Cardiovasc Intervent Radiol; 2022 Sep; 45(9):1304-1313. PubMed ID: 35922562
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intra arterial hepatic chemotherapy for unresectable colorectal metastases: (review).
    Abdulaal Y; Ross P; Heaton N
    Gulf J Oncolog; 2007 Jan; 1(1):77-92. PubMed ID: 20084717
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chemosaturation for primary and secondary liver malignancies: A comprehensive update of current evidence.
    Vogel A; Ochsenreither S; Zager JS; Wacker F; Saborowski A
    Cancer Treat Rev; 2023 Feb; 113():102501. PubMed ID: 36587472
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The past decade of experience with isolated hepatic perfusion.
    Grover A; Alexander HR
    Oncologist; 2004; 9(6):653-64. PubMed ID: 15561809
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regional therapy in metastatic melanoma: an update on minimally invasive intraarterial isolated limb infusion and percutaneous hepatic perfusion.
    Rashid OM; Sloot S; Zager JS
    Expert Opin Drug Metab Toxicol; 2014 Oct; 10(10):1355-64. PubMed ID: 25176398
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Selective intra-arterial chemotherapy with floxuridine as second- or third-line approach in patients with unresectable colorectal liver metastases.
    Samaras P; Breitenstein S; Haile SR; Stenner-Liewen F; Heinrich S; Feilchenfeldt J; Renner C; Knuth A; Pestalozzi BC; Clavien PA
    Ann Surg Oncol; 2011 Jul; 18(7):1924-31. PubMed ID: 21207165
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemosaturation Percutaneous Hepatic Perfusion (CS-PHP) with Melphalan: Evaluation of 2D-Perfusion Angiography (2D-PA) for Leakage Detection of the Venous Double-Balloon Catheter.
    Dewald CLA; Meine TC; Winther HMB; Kloeckner R; Maschke SK; Kirstein MM; Vogel A; Wacker FK; Meyer BC; Renne J; Hinrichs JB
    Cardiovasc Intervent Radiol; 2019 Oct; 42(10):1441-1448. PubMed ID: 31089781
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Up-front systemic chemotherapy is a feasible option compared to primary tumor resection followed by chemotherapy for colorectal cancer with unresectable synchronous metastases.
    Niitsu H; Hinoi T; Shimomura M; Egi H; Hattori M; Ishizaki Y; Adachi T; Saito Y; Miguchi M; Sawada H; Kochi M; Mukai S; Ohdan H
    World J Surg Oncol; 2015 Apr; 13():162. PubMed ID: 25908502
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatic resection for metastatic melanoma: distinct patterns of recurrence and prognosis for ocular versus cutaneous disease.
    Pawlik TM; Zorzi D; Abdalla EK; Clary BM; Gershenwald JE; Ross MI; Aloia TA; Curley SA; Camacho LH; Capussotti L; Elias D; Vauthey JN
    Ann Surg Oncol; 2006 May; 13(5):712-20. PubMed ID: 16538410
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Isolated hepatic perfusion with oxaliplatin combined with 100 mg melphalan in patients with metastases confined to the liver: A phase I study.
    van Iersel LB; de Leede EM; Vahrmeijer AL; Tijl FG; den Hartigh J; Kuppen PJ; Hartgrink HH; Gelderblom H; Nortier JW; Tollenaar RA; van de Velde CJ
    Eur J Surg Oncol; 2014 Nov; 40(11):1557-63. PubMed ID: 25125340
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Isolated hepatic perfusion: principles and results.
    Facy O; Doussot A; Zinzindohoué F; Holl S; Rat P; Ortega Deballon P
    J Visc Surg; 2014 Apr; 151 Suppl 1():S25-32. PubMed ID: 24582276
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prospective evaluation of percutaneous hepatic perfusion with melphalan as a treatment for unresectable liver metastases from colorectal cancer.
    Meijer TS; Dieters JHN; de Leede EM; de Geus-Oei LF; Vuijk J; Martini CH; van Erkel AR; Lutjeboer J; van der Meer RW; Tijl FGJ; Kapiteijn E; Vahrmeijer AL; Burgmans MC
    PLoS One; 2022; 17(1):e0261939. PubMed ID: 35025911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.